NCT07581418 Comparison of Methotrexate and Tofacitinib in Chronic Plaque Psoriasis Status NOT_YET_RECRUITING Phase NA
NCT07543640 EFFICACY OF ROFLUMILAST IN THE TREATMENT OF FLEXURAL AND/OR GENITAL PSORIASIS: A RANDOMIZED CONTROLLED TRIAL. Status NOT_YET_RECRUITING Phase PHASE2
NCT07498465 A Study to Find the Highest Dose of SNDX-5613 (Revumenib) as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, and Mixed Phenotype Acute Leukemia Status WITHDRAWN Phase PHASE1
NCT07446400 A Trial to Examine the Interaction of Repinatrabit With Ethinyl Estradiol/Norethindrone, Metformin,Carbamazepine, Rosuvastatin, and Methotrexate When Administered Together Status RECRUITING Phase PHASE1
NCT07432815 Treatment of Psoriasis With Depression and/or Anxiety With Methotrexate vs Combined Methotrexate and Antidepressant Status RECRUITING Phase PHASE4
NCT07432386 Methotrexate Versus Apremilast for Pruritus in Psoriasis Status NOT_YET_RECRUITING Phase PHASE4
NCT07388498 A Double-blind, Randomized Controlled Trial to Investigate the Efficacy, Safety, and Pharmacokinetics of Pegloticase Administration Via Subcutaneous and Intravenous Routes Both With Methotrexate in Participants With Uncontrolled Gout Status RECRUITING Phase PHASE3
NCT07176390 A Clinical Study of Tulisokibart (MK-7240) to Treat Rheumatoid Arthritis (RA) (MK-7240-014) Status RECRUITING Phase PHASE2
NCT06997068 Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent/Metastatic Head and Neck Cancer in a Rural Midwest United States Population Status RECRUITING Phase PHASE2
NCT06960577 Perioperative Durvalumab With Neoadjuvant ddMVAC or Gemcitabine/Cisplatin in Patients With Muscle-invasive Bladder Cancer (NIAGARA-2) Status RECRUITING Phase PHASE3
NCT06730542 Zanubrutinib in Combination With Pola-R-CHP and High-dose Methotrexate in Patients With Secondary CNS Lymphoma Status RECRUITING Phase PHASE1
NCT06533748 Therapy for Newly Diagnosed Patients With B-Cell Precursor Acute Lymphoblastic Leukemia and Lymphoma Status RECRUITING Phase PHASE2
NCT06476366 Comparison of Efficacy of Methotrexate and Azathioprine in Patients With Chronic Actinic Dermatitis: A Randomized Controlled Trial Status COMPLETED Phase EARLY_PHASE1
NCT06390319 Adding Dasatinib Or Venetoclax To Improve Responses In Children With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (ALL) Or Lymphoma (T-LLY) Or Mixed Phenotype Acute Leukemia (MPAL) Status RECRUITING Phase PHASE2
NCT06317662 Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia Status RECRUITING Phase PHASE2
NCT06301373 Methotrexate Combined With Tofacitinib in Rheumatoid Arthritis Status RECRUITING Phase NA
NCT06289673 Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma Status RECRUITING Phase PHASE4
NCT06204614 Drug Screening Using IMD in Bladder Cancer Status ENROLLING_BY_INVITATION Phase EARLY_PHASE1
NCT06177067 Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia Status RECRUITING Phase PHASE1